Lay’s recall increased to highest level, could cause ‘death’: FDA
The oversight could result in “death,” at least for those with a milk allergy or sensitivity, says the FDA. FDA initiated the ...
Axsome gets FDA approval for Symbravo for migraine
Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or ...